Insider Shareholders with Direct Ownership of Protagonist Therapeutics, Inc (PTGX)
This section provides a comprehensive overview of the insiders with direct ownership of Protagonist Therapeutics, Inc (PTGX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Protagonist Therapeutics, Inc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Canaan X L.P.
> 10% Shareholder |
0 | 336,703 | 2,116,552 $179 Million | 13 |
May 17, 2018
Reduced 1.81%
|
|
Dinesh V Ph D Patel
President and CEO |
625,881 | 449,676 | 614,943 $52 Million | 44 |
Jan 02, 2026
Added 13.43%
|
|
Suneel Gupta
Chief Development Officer |
346,825 | 136,709 | 267,433 $22.6 Million | 16 |
Nov 26, 2024
Added 0.17%
|
|
David Y Liu
Chief R&D Strategy Officer |
130,479 | 16,898 | 167,590 $14.2 Million | 6 |
Nov 16, 2022
Added 17.41%
|
|
Arturo Md Molina
Chief Medical Officer |
199,356 | 92,576 | 106,780 $9.03 Million | 20 |
Jan 02, 2026
Added 19.34%
|
|
Asif Ali
Chief Financial Officer |
163,657 | 76,992 | 86,665 $7.33 Million | 19 |
Jan 02, 2026
Added 22.8%
|
|
Harold E Selick
Director |
31,236 | 0 | 46,546 $3.94 Million | 5 |
Jan 02, 2026
Added 5.47%
|
|
Donald A. Kalkofen
Chief Financial Officer |
15,000 | 0 | 18,521 $1.57 Million | 2 |
Feb 15, 2022
Added 28.82%
|
|
Bryan Giraudo
Director |
7,825 | 0 | 17,825 $1.51 Million | 2 |
Jan 02, 2026
Added 13.13%
|
|
Samuel R Saks
Chief Medical Officer |
12,000 | 0 | 14,000 $1.18 Million | 1 |
Feb 26, 2021
Added 46.15%
|
|
William D. Waddill
Director |
68,800 | 60,975 | 7,825 $662,073 | 16 |
Jan 02, 2026
Added 25.62%
|
|
Sarah A O'Dowd
Director |
7,825 | 0 | 7,825 $662,073 | 2 |
Jan 02, 2026
Added 25.62%
|
|
Lewis T Williams
Director |
7,825 | 0 | 7,825 $662,073 | 2 |
Jan 02, 2026
Added 25.62%
|
|
Sarah B. Noonberg
Director |
8,400 | 8,400 | 0 $0 | 4 |
Feb 11, 2021
Reduced 100.0%
|